Clinical Trials Browser

Phase 1/2 × Withdrawn × infigratinib × Clear all

NCT05222165 2023-02-23

NEWEL

Phase 1/2 Withdrawn

Central Nervous System Neoplasms

NCT02575508 2016-05-20

Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer

Phase 1/2 Withdrawn

Gastrointestinal

Colonic Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms